autologous tumor lysate-pulsed dendritic cell vaccine (Medinet)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous tumor lysate-pulsed dendritic cell vaccine (Medinet)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungEsophageal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedinet

China Registration ClassN/A

Develop Information

Active CompaniesMedinet

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsCarcinoma, Non-Small-Cell LungEsophageal Neoplasms

Other Information

ATC CodeN/A